Turnover of human tissue plasminogen activator (tPA) in rabbits - PubMed (original) (raw)
Comparative Study
Turnover of human tissue plasminogen activator (tPA) in rabbits
D P Beebe et al. Thromb Res. 1986.
Abstract
The turnover of purified tissue plasminogen activator (tPA) from two different manufacturers was compared in rabbits. The first was melanoma derived one-chain tPA and the second was recombinant two-chain tPA. No differences were noted between the two products. A biphasic disappearance curve was observed for the protein (125Iodine labelled). The first phase was extremely rapid with a T1/2 of 0.59-0.89 min; the secondary phase had a T1/2 of 10-12 min. tPA accumulated rapidly in the liver (44% at twenty min) and appeared to be degraded as demonstrated by the increase in plasma of low molecular weight material which was also TCA soluble. Fractionation of purified recombinant two-chain tPA on a Dupont GF-250 column yielded two peaks of protein (Peak 1 and Peak 2) and the turnover of each in rabbits was compared.
Similar articles
- 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
Warshawsky I, Bu G, Schwartz AL. Warshawsky I, et al. J Clin Invest. 1993 Aug;92(2):937-44. doi: 10.1172/JCI116669. J Clin Invest. 1993. PMID: 8349826 Free PMC article. - Turnover of tissue plasminogen activator in normal and hepatectomized rabbits.
Nilsson S, Einarsson M, Ekvärn S, Häggroth L, Mattsson C. Nilsson S, et al. Thromb Res. 1985 Aug 15;39(4):511-21. doi: 10.1016/0049-3848(85)90174-4. Thromb Res. 1985. PMID: 3931294 - Turnover of tPA in rabbits: influence of carbohydrate moieties.
Beebe DP, Aronson DL. Beebe DP, et al. Thromb Res. 1988 Jul 1;51(1):11-22. doi: 10.1016/0049-3848(88)90278-2. Thromb Res. 1988. PMID: 3137690 - Uptake and degradation of tissue plasminogen activator in rat liver.
Einarsson M, Smedsrød B, Pertoft H. Einarsson M, et al. Thromb Haemost. 1988 Jun 16;59(3):474-9. Thromb Haemost. 1988. PMID: 3142083
Cited by
- Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.
Kuiper J, Van't Hof A, Otter M, Biessen EA, Rijken DC, van Berkel TJ. Kuiper J, et al. Biochem J. 1996 Feb 1;313 ( Pt 3)(Pt 3):775-80. doi: 10.1042/bj3130775. Biochem J. 1996. PMID: 8611154 Free PMC article. - 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
Warshawsky I, Bu G, Schwartz AL. Warshawsky I, et al. J Clin Invest. 1993 Aug;92(2):937-44. doi: 10.1172/JCI116669. J Clin Invest. 1993. PMID: 8349826 Free PMC article. - Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.
Collen D, Lijnen HR, Todd PA, Goa KL. Collen D, et al. Drugs. 1989 Sep;38(3):346-88. doi: 10.2165/00003495-198938030-00003. Drugs. 1989. PMID: 2509190 Review. - Binding of tissue plasminogen activator to human aortic endothelial cells.
Sanzo MA, Howard SC, Wittwer AJ, Cochrane HM. Sanzo MA, et al. Biochem J. 1990 Jul 15;269(2):475-82. doi: 10.1042/bj2690475. Biochem J. 1990. PMID: 2117440 Free PMC article. - Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
Bu G, Williams S, Strickland DK, Schwartz AL. Bu G, et al. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7427-31. doi: 10.1073/pnas.89.16.7427. Proc Natl Acad Sci U S A. 1992. PMID: 1502154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources